Something fascinating about GLP-1 drugs researchers are discovering

GLP-1 drugs like Ozempic and Wegovy are widely known for weight loss.

But researchers are starting to notice something surprising.

They may reduce cravings for addictive substances.

Early research suggests people taking GLP-1 drugs show lower rates of:

• alcohol use disorder
• opioid addiction
• nicotine dependence
• cocaine use

The reason appears to be neurological.

These drugs act on dopamine reward pathways in the brain — the same circuitry involved in addiction.

They’re not approved for addiction treatment yet.

But if the research holds up, this could represent a major shift in how medicine treats cravings.

Curious what others think.

Full breakdown here.